Adverse Effects of Transdermal Opiates Treating Moderate-Severe Cancer Pain in Comparison to Long-Acting Morphine: A Meta-Analysis and Systematic Review of the Literature

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Palliative Medicine

• Publication date

  2008-03-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/jpm.2007.0200PMID 18363493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Address Reprint Requests To

  2007cited by this paper
• Buprenorphine in long-term control of chronic pain in cancer patients.

  2007cited by this paper
• Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy

  2006cited by this paper
• Methodological and structural challenges in palliative care research: how have we fared in the last decades?

  2006cited by this paper
• A validation study of the WHO analgesic ladder: a two-step vs three-step strategy

  2005cited by this paper
• Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network

  2005cited by this paper
• Opioid purchases and expenditure in nine western European countries: ‘Are we killing off morphine?’

  2005cited by this paper
• Bmc Medical Research Methodology Open Access Evaluating the Role of Quality Assessment of Primary Studies in Systematic Reviews of Cancer Practice Guidelines

  2005cited by this paper
• Transdermal Fentanyl Versus Sustained Release Oral Morphine in Strong-Opioid Naïve Patients With Chronic Low Back Pain

  2005cited by this paper
• Use of strong opioids in advanced cancer pain: a randomized trial.

  2004cited by this paper
• Incidence of Constipation Associated with Long-acting Opioid Therapy: A Comparative Study

  2004cited by this paper
• Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain

  2004cited by this paper
• Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain

  2003cited by this paper
• Opioids in Italy: is marketing more powerful than the law?

  2003cited by this paper
• Quality of life at the end of life: how is the solution far away?

  2002cited by this paper
• Reply: Prediction of survival in terminally ill cancer patients: why we cannot avoid an evidence-based palliative medicine

  2002cited by this paper
• Quality-of-life assessment in palliative care.

  2002cited by this paper
• [Morphine and alternative opioids in cancer pain: the EAPC recommendations].

  2002cited by this paper
• Strategies to manage the adverse effects of oral morphine: an evidence-based report.

  2001cited by this paper
• Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain

  2001cited by this paper
• Morphine and alternative opioids in cancer pain: the EAPC recommendations

  2001cited by this paper
• Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer

  2001cited by this paper
• Treatment of cancer pain with transdermal fentanyl.

  2001cited by this paper
• Palliative care research.

  2001cited by this paper
• NR2: QUALITY OF LIFE AFTER SUBARACHNOID HEMORRHAGE IN RELATION TO RISK ESTIMATION BEFORE SURGERY

  2000cited by this paper
• Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine

  2000cited by this paper
• NR3: ECONOMIC EVALUATION OF TRANSDERMAL FENTANYL IN THE TREATMENT OF CHRONIC NON-CANCER PAIN IN DENMARK

  2000cited by this paper
• A comparison of subcutaneous morphine and fentanyl in hospice cancer patients.

  1999cited by this paper
• Cost of managing constipation among terminally ill cancer patients treated with transdermal fentanyl and 12 hour sustained-release morphine in Canada

  1999cited by this paper
• Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

  1998cited by this paper
• Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.

  1998cited by this paper
• Transdermal fentanyl versussustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life

  1997cited by this paper
• Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain.

  1997cited by this paper
• Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group.

  1997cited by this paper
• Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain.

  1997cited by this paper
• The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation.

  1995cited by this paper
• Quality of life assessment in palliative care.

  1994cited by this paper
• A 2.|E|-Bit Distributed Algorithm for the Directed Euler Trail Problem

  1993cited by this paper

• Opioid consumption, availability, and policy alignment in primary hospice and palliative care in China: a multicomponent comparative analysis

  2026cites this paper
• High BMI predicts poor cancer pain relief when rotating from oral opioids to transdermal Fentanyl: a two-center retrospective study

  2025cites this paper
• Successful Initiation of Buprenorphine for Chronic Non-Cancer Pain in an Opioid-Experienced Patient: A Case Report

  2025cites this paper
• Developing a machine learning-based predictive model for the analgesic effectiveness of transdermal fentanyl in cancer patients: an interpretable approach

  2025cites this paper
• Efficacy of prophylactic laxatives against opioid-induced constipation: retrospective propensity score matching analysis

  2025cites this paper
• Buprenorphine: an old dog with new tricks

  2025cites this paper
• Opioid induced constipation: mechanisms and management.

  2025cites this paper
• Background and Breakthrough Opioid Choice May Determine Different Pain Outcomes.

  2023cites this paper
• Aloe Vera -Containing Matrix in Transdermal Fentanyl Therapy Improves Adhesion, Skin Tolerance and Quality of Life: Results of a German Multicenter Study with a New Fentanyl Patch

  2022cites this paper
• Transdermal opioids for acute postoperative pain: A road less travelled!

  2022cites this paper
• Management of Opioid-induced Constipation in Older Adults

  2022cites this paper
• Transdermal opioids for acute postoperative pain: A road less travelled!

  2022cites this paper
• Rabbits (Oryctolagus cuniculus) as a Model System for Longitudinal Experimental Opioid Treatments: Implications for Orthopedic and Biomedical Research

  2021cites this paper
• Comparative evaluation of analgesic efficacy of buprenorphine transdermal patch and fentanyl patch in management of postoperative pain after arthroscopic lower limb surgery: A randomized controlled trial

  2021cites this paper
• Opioid Use in the Treatment of Pain States

  2021cites this paper
• Consideration of Opioid Induction Appropriate Cases for Cancer Pain Using Fentos® Tape 0.5 mg

  2021cites this paper
• Managing pain in oncology

  2020cites this paper
• Management of osteoarthritis during COVID-19 pandemic

  2020cites this paper
• Fentanyl, Morphine, and Opioid-Induced Constipation in Patients with Cancer-Related Pain

  2020cites this paper
• A randomized comparative study to evaluate efficacy and safety of transdermal buprenorphine patch with transdermal fentanyl patch as Pre-emptive analgesia in postoperative pain control in patients undergoing mastectomy surgery

  2020cites this paper
• Transdermal buprenorphine patch versus oral celecoxib for pain management after total knee arthroplasty: An open- label, randomized controlled trial.

  2020cites this paper
• Opioid-induced constipation in patients with cancer: a “real-world,” multicentre, observational study of diagnostic criteria and clinical features

  2020cites this paper
• Indian Society for Study of Pain, Cancer Pain Special Interest Group Guidelines on Pharmacological Management of Cancer Pain (Part II)

  2020cites this paper
• Management of Osteoarthritis During the COVID‐19 Pandemic

  2020cites this paper
• Evaluating naloxegol for the treatment of opioid-induced constipation

  2020cites this paper
• Aktualisierte S3-Leitlinie „Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung“

  2020cites this paper
• Understanding transdermal buprenorphine and a practical guide to its use for chronic cancer and non-cancer pain management.

  2019cites this paper
• Consumption trends and prescription patterns of opioids from 2011 to 2016: a survey in a Chinese city

  2019cites this paper
• Pathophysiology and management of opioid-induced constipation: European expert consensus statement

  2019cites this paper
• The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain (Part I)

  2019cites this paper
• A Scoping Review of Transdermal Buprenorphine Use for Non-surgical Pain in the Pediatric Population

  2019cites this paper
• Opioid-induced constipation: a narrative review of therapeutic options in clinical management

  2019cites this paper
• Fentanyl Pharmacokinetics : the role of clinical factors in patients with cancer using transdermal or sublingual fentanyl

  2019cites this paper
• Methadone versus Fentanyl in Patients with Radiation‐Induced Nociceptive Pain with Head and Neck Cancer: A Randomized Controlled Noninferiority Trial

  2018cites this paper
• Opioid use in gynecologic oncology in the age of the opioid epidemic: Part I - Effective opioid use across clinical settings, a society of gynecologic oncology evidence-based review.

  2018cites this paper
• Health benefits of an adverse events reporting system for chronic pain patients using long‐term opioids

  2018cites this paper
• Consumption trend and prescription pattern of opioid analgesics in China from 2006 to 2015

  2018cites this paper
• Progress in understanding mechanisms of opioid‐induced gastrointestinal adverse effects and respiratory depression

  2018cites this paper
• Long-acting Opioid Use and the Risk of Serious Infections: A Retrospective Cohort Study.

  2018cites this paper
• Bioanalytical methods for the quantification of hydromorphone, fentanyl, norfentanyl, morphine, morphine‐3ß‐glucuronide and morphine‐6ß‐glucuronide in human plasma

  2018cites this paper
• Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer

  2018cites this paper
• A systematic review of pharmacologic management in oncology

  2018cites this paper
• Constipations as a side effect of opioid anti-pain therapy – current and future treatment methods

  2018cites this paper
• Pathophysiology, diagnosis, and management of opioid-induced constipation.

  2018cites this paper
• Strong opioid analgesics in therapy for chronic pain syndrome. Which drug should be preferred

  2017cites this paper
• A meta-analysis of randomized controlled trials

  2017cites this paper
• Alghedon Fentanyl Transdermal System.

  2017cites this paper
• Efficacy of transdermal buprenorphine patch on post-operative pain relief after elective spinal instrumentation surgery

  2017cites this paper
• Palliative care in ovarian carcinoma patients—a personalized approach of a team work: a review

  2017cites this paper
• Treat chronic pain with appropriate non-oral formulations of opioids in patients who have difficulty swallowing

  2017cites this paper
• The Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A Review

  2017cites this paper
• Adductor canal block with local infiltrative analgesia compared with local infiltrate analgesia for pain control after total knee arthroplasty

  2017cites this paper
• Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review

  2017cites this paper
• Is there a role for pharmacogenetics in the dosing of fentanyl?

  2017cites this paper
• Options for Treating Pain in Cancer Patients with Dysphagia

  2017cites this paper
• Treat chronic pain with appropriate non-oral formulations of opioids in patients who have difficulty swallowing

  2017cites this paper
• Schmerztherapie in der Palliativmedizin

  2017cites this paper
• Transcutaneous electrical nerve stimulation for postoperative pain control after total knee arthroplasty

  2017cites this paper
• Liposomal bupivacaine versus interscalene nerve block for pain control after total shoulder arthroplasty: A systematic review and meta-analysis.

  2017cites this paper
• Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients

  2016cites this paper
• Outcomes of Treatment with Opioids - the role of clinical, pharmacokinetic and genetic factors

  2016influential citation
• Computational-aided design of magnetic ultra-thin dummy molecularly imprinted polymer for selective extraction and determination of morphine from urine by high-performance liquid chromatography.

  2016cites this paper
• Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications.

  2016cites this paper
• Management of opioid-induced constipation.

  2016cites this paper
• The Neuropathology of Drug Addictions and Substance Misuse: Assays for Fentanyl

  2016cites this paper
• Safety concerns with long-term opioid use

  2016cites this paper
• The effectiveness of buprenorphine for treating cancer pain: an abridged Cochrane review

  2015cites this paper
• New Options in Constipation Management

  2015cites this paper
• The unique role of transdermal buprenorphine in the global chronic pain epidemic.

  2015cites this paper
• ResearchEfficacy and adverse effects of transdermal fentanyl and sustained-release oral morphine in treating moderate-severe cancer pain in Chinese population : a systematic review and meta-analysis

  2015cites this paper
• Comparison between Transdermal Buprenorphine and Transdermal Fentanyl for Postoperative Pain Relief after Major Abdominal Surgeries.

  2015cites this paper
• Constipation: opioid antagonists in people prescribed opioids.

  2015cites this paper
• Management of opioid-induced constipation for people in palliative care.

  2015cites this paper
• Buprenorphine for treating cancer pain.

  2015cites this paper
• A Systematic Review of Prospective Studies Reporting Adverse Events of Commonly Used Opioids for Cancer-Related Pain: A Call for the Use of Standardized Outcome Measures.

  2015cites this paper
• Opioid-Induced Constipation.

  2015cites this paper
• Opioid-Induced Adverse Effects and Toxicity

  2014cites this paper
• Side effects of analgesia may significantly reduce quality of life in symptomatic multiple myeloma: a cross-sectional prevalence study

  2014cites this paper
• Constipation in the Long-Term Care Setting

  2014cites this paper
• Farmakokinetika i farmakodinamika analgetika

  2014cites this paper
• Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid‐induced constipation

  2014cites this paper
• Constipation in cancer patients – the management recommendations of the Expert Group of the Polish Association for Palliative Medicine

  2014cites this paper
• Direct effects of morphine but not of fentanyl‐type opioids on human 5‐HT3A receptors in outside‐out patch‐clamp studies

  2014cites this paper
• Improving Pain Experience in Cancer Patients

  2014cites this paper
• Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain

  2014cites this paper
• Buprenorphine: Side Effects and Tolerability

  2013cites this paper
• THE TOPICAL PAIN RELIEF REVOLUTION: PRINCIPLES AND PRACTICE OF COMPOUNDING PHARMACY

  2013cites this paper
• Dyspepsia and Opioid–Induced Bowel Dysfunction: The Role of Opioid Receptor Antagonists

  2013cites this paper
• PRINCIPLES AND PRACTICE OF COMPOUNDING PHARMACY

  2013cites this paper
• Zaparcia indukowane opioidami w bólu przewlekłym — praktyczne aspekty zastosowania połączenia oksykodonu z naloksonem

  2013cites this paper
• Serum Concentration of Fentanyl During Conversion From Intravenous to Transdermal Administration to Patients With Chronic Cancer Pain

  2013cites this paper
• Pharmacological characteristics and clinical application of trans- dermal fentanyl in cancer pain management

  2013cites this paper
• The evaluation of management of pain in elderly cancer patients receiving home-based care : the questionnaire with online system

  2013cites this paper
• Differences between opioids: pharmacological, experimental, clinical and economical perspectives

  2013cites this paper
• Buprenorphine Analgesia in Chronic Pain

  2013cites this paper
• The role of fentanyl in refractory opioid-related acute colonic pseudo-obstruction.

  2013cites this paper
• Transdermal fentanyl for cancer pain.

  2013cites this paper
• Analgesic Effect of Switching From Oral Opioids to a Once-a-Day Fentanyl Citrate Transdermal Patch in Patients With Lung Cancer

  2013cites this paper
• Pain and its Management

  2012cites this paper
• Are we able to Manage Effectively Opioid-Induced Bowel Dysfunction?

  2012cites this paper